Loading...
Initial results of a CRUK phase I/II, first in human trial of the CAR t-cell engager protein aleta-001 in patients who have received anti-CD19 CAR t-cell therapy for the treatment of b-cell malignancies
Chaganti, S. Townsend, W. Maybury, B. Paneesha, S. Peacock, V. Feast, A. Malladi, R. Uttenthal, B. Burton, C. Owen, M.
Chaganti, S.
Townsend, W.
Maybury, B.
Paneesha, S.
Peacock, V.
Feast, A.
Malladi, R.
Uttenthal, B.
Burton, C.
Owen, M.
Abstract
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 171.51 KB
Keywords
Type
Article
Citation
Chaganti S, Townsend W, Maybury B, Paneesha S, Peacock V, Feast A, et al. Initial results of a CRUK phase I/II, first in human trial of the CAR t-cell engager protein aleta-001 in patients who have received anti-CD19 CAR t-cell therapy for the treatment of b-cell malignancies. Blood. 2025 NOV 3;146:925-6.